Title: Contextualized Networks Reveal Heterogeneous Transcriptomic Regulation in Tumors at Sample-Specific Resolution
Authors: Caleb N. Ellington, Benjamin J. Lengerich, Thomas B.K. Watkins, Jiekun Yang, Manolis Kellis, Eric P. Xing
Section: 
43 1 43 91 (b) Network subtypes survival function OV CA .D iff er en tia te d OV CA .Im m un or ea ct iv e OV CA .M es en ch ym al OV CA .P ro lif er at iv e NA TCGA Subtype OV .N et .1 OV .N et .2 OV .N et .3 OV .N et .4 NA Ne tw or k Su bt yp e 14 12 4 18 1 7 14 15 20 2 37 14 16 15 2 27 32 41 35 2 50 35 33 50 0 Subtype Cross-Tabulation by Patient Counts (c) Network subtypes crosstabulation with known subtype BCL11B Major Allele Amplified (-log(p) = 5.2) MLLT10 Major Allele Amplified (-log(p) = 5.3) TNFAIP3 Gene Loss of Heterozygosity (-log(p) = 5.4) MTOR Gene Loss of Heterozygosity (-log(p) = 5.4) CCNE1 Major Allele Amplified (-log(p) = 5.8) CASP9 Gene Loss of Heterozygosity (-log(p) = 5.8) PRDM2 Gene Loss of Heterozygosity (-log(p) = 6.0) SKI Gene Loss of Heterozygosity (-log(p) = 6.1) HSP90AA1 Major Allele Amplified (-log(p) = 6.2) EZR Gene Loss of Heterozygosity (-log(p) = 6.9) Ploidy (-log(p) = 12.8) Purity (-log(p) = 4.4) Stage (-log(p) = 0.1) Age at Diagnosis (-log(p) = 6.0) Race (-log(p) = 1.6) TCGA Subtype Network Subtype Network Subtype OV.Net.1 OV.Net.2 OV.Net.3 OV.Net.4 TCGA Subtype OVCA.Differentiated OVCA.Immunoreactive OVCA.Mesenchymal OVCA.Proliferative Race american indian or alaska native asian black or african american native hawaiian or other pacific islander not reported white Stage 1.0 2.0 3.0 4.0 1.6 3.5 5.3 Ploidy 0.21 0.57 0.92 Purity 30 58 87 Age at Diagnosis −1 −0.5 0 0.5 1 OV Oncoplot Figure S16: Exploration of network subtypes for Ovarian serous cystadenocarcinoma (OV), looking at correlated clinical information, arm-level copy alterations, gene-level copy alterations, and gene-level single nucleotide variations. S21 0 500 1000 1500 2000 timeline 0.0 0.2 0.4 0.6 0.8 1.0 ['PAAD'] Subtype_Selected Survival Function plotting shared samples only p-value 0.36372104750251555 PAAD.ADEX (18/36) PAAD.immunogenic (17/26) PAAD.progenitor (17/48) PAAD.squamous (10/27) PAAD.ADEX (18/36) At risk 35 Censored 1 Events 0 PAAD.immunogenic (17/26) At risk 26 Censored 0 Events 0 PAAD.progenitor (17/48) At risk 48 Censored 0 Events 0 PAAD.squamous (10/27) At risk 27 Censored 0 Events 0 14 10 12 9 13 4 21 6 21 10 3 14 4 14 18 3 16 7 7 13 28 2 9 16 2 16 18 1 17 8 2 16 30 1 10 16 1 17 18 0 17 9 2 16 30 1 10 16 (a) Known subtypes survival function 0 500 1000